LYPD5 Activators
LYPD5 can affect the protein's function through various biochemical signaling pathways. Phorbol 12-myristate 13-acetate (PMA), a potent activator of protein kinase C (PKC), can lead to the phosphorylation of LYPD5. The activation of PKC, which can be triggered by PMA, facilitates the transfer of phosphate groups to LYPD5, altering its activity. Similarly, Ionomycin, by increasing intracellular calcium levels, can activate calcium-dependent kinases like PKC, which may then target LYPD5. Forskolin raises intracellular cAMP levels by directly stimulating adenylyl cyclase, leading to the activation of protein kinase A (PKA), which can also phosphorylate LYPD5. Another compound, Dibutyryl-cAMP (db-cAMP), a cAMP analog, activates PKA, which subsequently may phosphorylate LYPD5, thereby affecting its function.
Epidermal Growth Factor (EGF) activates a cascade of phosphorylation events through its receptor EGFR, which can influence the activity of LYPD5 by modifying proteins that interact with it. Insulin, upon binding to its receptor, initiates signaling pathways that can lead to the phosphorylation of proteins within LYPD5's pathway. Bombesin and Bradykinin, through their respective receptors, stimulate phospholipase C, leading to PKC activation, which can have downstream effects on LYPD5. Isoproterenol, a beta-adrenergic agonist, increases cAMP, thereby activating PKA, which in turn may phosphorylate and affect LYPD5. Anisomycin, through the activation of stress-activated protein kinases, can lead to phosphorylation events that modify LYPD5 activity. Thapsigargin, by disrupting calcium homeostasis, can activate pathways involving PKC that may impinge upon LYPD5. Lastly, retinoic acid can modulate kinase signaling pathways that phosphorylate proteins associated with LYPD5, altering its function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which is known to phosphorylate a wide variety of protein targets. Given that LYPD5 is a transmembrane protein, PKC-mediated phosphorylation can lead to the activation of LYPD5 by changing its conformation or interaction with other cellular components. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent protein kinases such as PKC. PKC activation can then lead to the activation of LYPD5 through phosphorylation or other regulatory mechanisms involving calcium signaling. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin receptor activation stimulates multiple signaling pathways, including the PI3K/Akt pathway. Activation of Akt can result in the phosphorylation of a range of cellular proteins, potentially including those that regulate LYPD5, leading to its activation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cell-permeable cAMP analog that activates PKA. Activated PKA can phosphorylate proteins within the pathway that includes LYPD5, resulting in the functional activation of LYPD5 through secondary messenger systems. | ||||||
Bombesin | 31362-50-2 | sc-397365 | 1 mg | $81.00 | ||
Bombesin functions through G protein-coupled receptors to activate PLC, which leads to PKC activation. The subsequent activation of PKC can phosphorylate and activate LYPD5 as part of a signaling cascade. | ||||||
Bradykinin | 58-82-2 | sc-507311 | 5 mg | $110.00 | ||
Bradykinin activates its G protein-coupled receptors, leading to the activation of PLC and the subsequent production of IP3 and DAG, which activate PKC. Activated PKC may then phosphorylate and activate LYPD5 within its pathway. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that activates adenylyl cyclase via G protein-coupled receptors, increasing cAMP and activating PKA. PKA can then potentially phosphorylate proteins that regulate LYPD5, leading to its activation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that can activate stress-activated protein kinases (SAPK) pathways. Activation of these kinases can lead to phosphorylation events that activate LYPD5 as part of the cellular stress response. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor which leads to an increase in cytosolic calcium levels, potentially activating calcium-dependent kinases like PKC. PKC may then phosphorylate and activate LYPD5 within its associated pathways. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can influence gene expression and modulate kinase signaling pathways. Certain kinases regulated by retinoic acid may phosphorylate and activate proteins that are involved in the same pathway as LYPD5, leading to its functional activation. | ||||||